EYE vs SPL

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

EYE

NOVA EYE FPO [EYE]

58MEDIUM

SPL

STARPHARMA FPO [SPL]

56MEDIUM

Score Breakdown

EYE SPL
Technical
46
58
Catalyst
54
68
Sentiment
50
50
Fundamental
60
58
Momentum
65
63
Risk Gate
50
50

Key Metrics

EYE Metric SPL
$38.5MMarket Cap$345.9M
199KAvg Volume (20d)2.9M
N/AShort Interest+0.0%
$0.20552-Week High$0.815
$0.10052-Week Low$0.110
+3.8%Daily Change+2.1%
$0.135Reference Price$0.735
-26.1%ROE-45.6%
-12.4%Profit Margin-58.9%

Active Signals

EYE Signals

●Stochastic just turned bullish from a low level — early reversal sign
●Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.2 quarters)
●Low P/S ratio (1.1x)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+10pts)
●Small-cap ($20-100M)

SPL Signals

●Stochastic just turned bullish from a low level — early reversal sign
●Death cross triggered — the short-term trend just crossed below the long-term, which is a bearish signal
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (14 quarters)
●Revenue in sharp decline (-56%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare EYE and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IMM vs NOX →CGS vs SPL →AHC vs NOX →ARX vs CGS →ATX vs CGS →
EYE Full Analysis → SPL Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).